Immediate Impact
3 from Science/Nature 51 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Targeting KRAS in cancer
2024 Standout
Works of Jeffrey A. Klomp being referenced
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
2023
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jeffrey A. Klomp | 216 | 49 | 59 | 16 | 338 | |
| Tetsuo Kon | 219 | 71 | 70 | 22 | 386 | |
| Ashley N. Sigafoos | 180 | 49 | 61 | 14 | 315 | |
| Pascal J. Lafontant | 296 | 50 | 36 | 16 | 394 | |
| David Strehlow | 197 | 61 | 56 | 17 | 408 | |
| Pengfei Xu | 241 | 36 | 39 | 14 | 321 | |
| Joey Riepsaame | 306 | 42 | 32 | 10 | 375 | |
| Sophie Colombo | 295 | 103 | 42 | 17 | 394 | |
| Jérôme Cartry | 244 | 40 | 92 | 11 | 378 | |
| Erika Yamada | 193 | 108 | 146 | 18 | 405 | |
| Tracy A. Stevens | 279 | 58 | 93 | 9 | 396 |
All Works
Login with ORCID to disown or claim papers
Loading papers...